MED PRESS-RELEASE SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

MED ▲ +0.88% at T+5d

NEUTRAL call ✓ call won +0.88% · α vs SPY -0.08% · entry $12.48 → $12.59

Next anchor: T+20d in 5d

Last close $12.07 (close Jun 8) · -3.29% from $12.48 entry

Entry anchored
May 15, 12:59 PM ET
via Databento tick

T+1d

-0.24%

call -0.24% · α -0.18%

$12.45

settled 23d ago

T+5d

+0.88%

call +0.88% · α -0.08%

$12.59

settled 19d ago

T+20d

—

call — · α —

—

in 5d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Medifast issued a press release promoting OPTAVIA's clinical evidence for visceral fat reduction and lean mass preservation, citing 18 randomized controlled trials and a 14% visceral fat reduction with 98% lean mass retention over 16 weeks. The release is a marketing/educational piece with no financial data, guidance, or material corporate events.

Actionable Insight

This press release is non-material and unlikely to move the stock. Monitor upcoming quarterly earnings for financial performance and any changes in customer acquisition or retention metrics.

Key Facts

Press release highlights OPTAVIA's clinical data: 14% visceral fat reduction and 98% lean mass retention over 16 weeks.
No financial results, guidance, or material corporate events disclosed.
Company cites 18 randomized controlled trials and 30+ scientific studies supporting its program.
No new product launches, regulatory approvals, or partnership announcements.

Financial Impact

No financial impact — press release is educational/marketing content without financial data.

Risk Factors

No financial data provided — unable to assess business performance from this release.
Press release may be viewed as a marketing effort with no new catalysts.

Market Snapshot

Exchange

NYSE

Sector

Miscellaneous Food Preparations & Kindred Products

Analyst Consensus

0% bullish (9 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3296058

7 reports for MED

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for MED — sortable, filterable
	Type				Now
Jun 1, 2026 8d ago	8-K NEUTRAL ★ 2/10	$12.70 $12.10	▼ −4.72%	▼ −1.97%	$12.07 (−4.96%)
May 26, 2026 14d ago	8-K NEUTRAL ★ 3/10	$12.72 $12.36	▼ −2.83%	▼ −4.04%	$12.07 (−5.11%)
May 21, 2026 19d ago	Press Release NEUTRAL ★ 2/10	$12.63 $12.53	▼ −0.79%	▼ −2.64%	$12.07 (−4.43%)
May 21, 2026 19d ago	Press Release NEUTRAL ★ 2/10	$12.63 $12.53	▼ −0.79%	▼ −2.64%	$12.07 (−4.43%)
May 15, 2026 25d ago	Press Release NEUTRAL ★ 2/10	$12.48 $12.59	▲ +0.88%	▼ −0.08%	$12.07 (−3.29%)
May 15, 2026 25d ago	Press Release NEUTRAL ★ 2/10	$12.48 $12.59	▲ +0.88%	▼ −0.08%	$12.07 (−3.29%)
May 4, 2026 5w ago	8-K BEARISH ★ 7/10	$13.02 $12.57	▲ +3.46%	▲ +5.44%	$12.07 (+7.30%)

US Market Status

Market Closed — Opens in 6h 36m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access